Alkylphosphocholines : new drugs in cancer therapy

著者

• Eibl, H.
• Hilgard, P.
• Unger, C.

書誌事項

Alkylphosphocholines : new drugs in cancer therapy

volume editors, H. Eibl, P. Hilgard, C. Unger

（Progress in experimental tumor research, v. 34）

Karger, 1992

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Alkylphosphocholines represent a new and exciting class of antineoplastic agents, discovered by Eibl and Unger, displaying numerous biological effects. The research presented in this volume focuses on the biological properties of hexadecylphosphocholine (PHC) - the prototype of this class and one of the first lipid-derived anticancer compounds to be brought from the experimental stage to clinical trial. The contributions, authored by scientists directly involved in these developments, discuss the selective antineoplastic activity of HPC both in vitro and in vivo as well as the application of HPC in the topical treatment of skin metastases resulting from breast cancer and lymphomas. Summarizing what is now known about the biological activities of alkylphosphocholines and their potential as antitumour drugs, this book contains new information for cancer researchers, oncologists and pharmacologists.

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BA18495621
• ISBN:
  • 3805554648
• 出版国コード: sz
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: Basel ; Tokyo
• ページ数/冊数: x, 173 p.
• 大きさ: 25 cm
• 親書誌ID:
  • BA00823185